UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 405

Sortiert nach

European guidelines on the clinical management of HIV-1 tropism testing

The Lancet infectious diseases, 2011-05, Vol.11 (5), p.394-407

2011

Volltextzugriff (PDF)

Phylogenetic Analysis of 49 Newly Derived HIV-1 Group O Strains: High Viral Diversity but No Group M-like Subtype Structure

Virology (New York, N.Y.), 2002-10, Vol.302 (2), p.259-273

2002

Volltextzugriff (PDF)

Salivary Cytomegalovirus (CMV) Shedding, Glycoprotein B Genotype Distribution, and CMV Disease in Human Immunodeficiency Virus-Seropositive Patients

Clinical infectious diseases, 2001-10, Vol.33 (8), p.1406-1411

2001

Volltextzugriff (PDF)

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (5), p.914-920

2008

Volltextzugriff (PDF)

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France

Journal of Virology, 1995-09, Vol.69 (9), p.5640-5649

1995

Volltextzugriff (PDF)

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance

Journal of clinical virology, 2005-05, Vol.33 (1), p.75-78

2005

Volltextzugriff (PDF)

Cytomegalovirus (CMV) Viremia and the CD4+ Lymphocyte Count as Predictors of CMV Disease in Patients Infected with Human Immunodeficiency Virus

Clinical infectious diseases, 1997-05, Vol.24 (5), p.836-840

1997

Volltextzugriff (PDF)

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV‐infected patients

HIV medicine, 2004-07, Vol.5 (4), p.307-313

2004

Volltextzugriff (PDF)

Update on the Human Immunodeficiency Virus

Médecine et maladies infectieuses, 2013-05, Vol.43 (5), p.177-184

2013

Volltextzugriff (PDF)

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.1972-1975

2011

Volltextzugriff (PDF)

V3 Serological Subtyping of Human Immunodeficiency Virus Type 2 Infection Is Not Relevant

Journal of Clinical Microbiology, 2001-10, Vol.39 (10), p.3803-3807

2001

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays

Journal of Clinical Microbiology, 2007-10, Vol.45 (10), p.3436-3438

2007

Volltextzugriff (PDF)

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

Science (American Association for the Advancement of Science), 1983-05, Vol.220 (4599), p.868-871

1983

Volltextzugriff (PDF)

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

AIDS (London), 2012-01, Vol.26 (3), p.303-314

2012

Volltextzugriff (PDF)

Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

Journal of Clinical Microbiology, 2010-04, Vol.48 (4), p.1413-1416

2010

Volltextzugriff (PDF)

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O

Nature medicine, 1998-09, Vol.4 (9), p.1032-1037

1998

Volltextzugriff (PDF)

Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral Therapy

Journal of Virology, 2001-07, Vol.75 (14), p.6410-6417

2001

Volltextzugriff (PDF)

Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study)

HIV medicine, 2011-04, Vol.12 (4), p.211-218

2011

Volltextzugriff (PDF)

Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions

AIDS (London), 1996-12, Vol.10 (14), p.F57-F60

1996

Volltextzugriff (PDF)

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

Journal of antimicrobial chemotherapy, 2017-01, Vol.72 (1), p.240-245

2017

Volltextzugriff (PDF)

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

The Lancet (British edition), 1994-06, Vol.343 (8910), p.1393-1394

1994

Volltextzugriff (PDF)

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2910-2919

2010

Volltextzugriff (PDF)

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1816-1824

2015

Volltextzugriff (PDF)

HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients

The Lancet (British edition), 1994-06, Vol.343 (8910), p.1393-1394

1994

Volltextzugriff (PDF)

1 – 25 von 405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(338)
Mit Volltextzugriff
(332)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(301)
Science & Technology
(249)
Life Sciences & Biomedicine
(245)
Infectious Diseases
(192)
Biological And Medical Sciences
(172)
Aids/hiv
(162)
Medical Sciences
(162)
Male
(152)
Virology
(148)
Female
(145)
Adult
(135)
Hiv Infections - Virology
(122)
Hiv Infections - Drug Therapy
(113)
Hiv-1 - Genetics
(107)
Immunology
(95)
Viral Diseases
(94)
Human Viral Diseases
(93)
Microbiology
(91)
Human Immunodeficiency Virus 1
(88)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(83)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

European guidelines on the clinical management of HIV-1 tropism testing

Phylogenetic Analysis of 49 Newly Derived HIV-1 Group O Strains: High Viral Diversity but No Group M-like Subtype Structure

Salivary Cytomegalovirus (CMV) Shedding, Glycoprotein B Genotype Distribution, and CMV Disease in Human Immunodeficiency Virus-Seropositive Patients

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance

Cytomegalovirus (CMV) Viremia and the CD4+ Lymphocyte Count as Predictors of CMV Disease in Patients Infected with Human Immunodeficiency Virus

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV‐infected patients

Update on the Human Immunodeficiency Virus

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism

V3 Serological Subtyping of Human Immunodeficiency Virus Type 2 Infection Is Not Relevant

Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011

Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O

Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral Therapy

Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study)

Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity

HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients

Suchergebnisse filtern